Stockreport

LENZ Therapeutics, Inc. Investigated by the Portnoy Law Firm

LENZ Therapeutics, Inc.  (LENZ) 
PDF LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises LENZ Therapeutics, Inc., (“LENZ" or the "Company") (NASDAQ: LENZ) investors that the firm [Read more]